{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:24:50Z","timestamp":1790727890333,"version":"4.1.0"},"reference-count":249,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2016,4,9]],"date-time":"2016-04-09T00:00:00Z","timestamp":1460160000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s40620-016-0305-6","type":"journal-article","created":{"date-parts":[[2016,4,9]],"date-time":"2016-04-09T11:24:02Z","timestamp":1460201042000},"page":"305-328","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Vitamin D in patients with chronic kidney disease: a position statement of the Working Group \u201cTrace Elements and Mineral Metabolism\u201d of the Italian Society of Nephrology"],"prefix":"10.1093","volume":"29","author":[{"given":"Luigi Francesco","family":"Morrone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pergiorgio","family":"Bolasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Camerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Cianciolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adamasco","family":"Cupisti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Galassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Mazzaferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Cozzolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,4,9]]},"reference":[{"key":"305_CR1","first-page":"1","volume":"810","author":"MF Holick","year":"2014","unstructured":"Holick MF (2014) Sunlight, ultraviolet radiation, vitamin D and skin cancer: how much sunlight do we need? Adv Exp Med Biol 810:1\u201316","journal-title":"Adv Exp Med Biol"},{"key":"305_CR2","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266\u2013281. doi: 10.1056\/NEJMra070553","journal-title":"N Engl J Med"},{"key":"305_CR3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00223-012-9634-1","volume":"92","author":"HM Macdonald","year":"2013","unstructured":"Macdonald HM (2013) Contributions of sunlight and diet to vitamin D status. Calcif Tissue Int 92:163\u2013176. doi: 10.1007\/s00223-012-9634-1","journal-title":"Calcif Tissue Int"},{"key":"305_CR4","doi-asserted-by":"publisher","first-page":"872","DOI":"10.231\/JIM.0b013e318214ea2d","volume":"59","author":"MF Holick","year":"2011","unstructured":"Holick MF (2011) Vitamin D: a d-lightful solution for health. J Investig Med 59:872\u2013880. doi: 10.231\/JIM.0b013e318214ea2d","journal-title":"J Investig Med"},{"key":"305_CR5","first-page":"390","volume":"810","author":"J Reichrath","year":"2014","unstructured":"Reichrath J, Reichrath S (2014) Sunlight, vitamin D and malignant melanoma: an update. Adv Exp Med Biol 810:390\u2013405","journal-title":"Adv Exp Med Biol"},{"key":"305_CR6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4161\/cbt.6.1.3493","volume":"6","author":"J Reichrath","year":"2007","unstructured":"Reichrath J, Rech M, Moeini M et al (2007) In vitro comparison of the vitamin D endocrine system in 1,25(OH)2D3-responsive and -resistant melanoma cells. Cancer Biol Ther 6:48\u201355","journal-title":"Cancer Biol Ther"},{"key":"305_CR7","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.jaad.2014.08.013","volume":"71","author":"KK Reddy","year":"2014","unstructured":"Reddy KK, Gilchrest BA (2014) The role of vitamin D in melanoma prevention: evidence and hyperbole. J Am Acad Dermatol 71:1004\u20131005. doi: 10.1016\/j.jaad.2014.08.013","journal-title":"J Am Acad Dermatol"},{"key":"305_CR8","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jsbmb.2010.03.003","volume":"121","author":"P Sertznig","year":"2010","unstructured":"Sertznig P, Seifert M, Tilgen W, Reichrath J (2010) Peroxisome proliferator-activated receptor (PPAR) and vitamin D receptor (VDR) signaling pathways in melanoma cells: promising new therapeutic targets? J Steroid Biochem Mol Biol 121:383\u2013386. doi: 10.1016\/j.jsbmb.2010.03.003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"305_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12863-015-0163-6","volume":"16","author":"W Hou","year":"2015","unstructured":"Hou W, Wan X, Fan J (2015) Variants Fok1 and Bsm1 on VDR are associated with the melanoma risk: evidence from the published epidemiological studies. BMC Genet 16:14. doi: 10.1186\/s12863-015-0163-6","journal-title":"BMC Genet"},{"key":"305_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4161\/derm.25244","volume":"5","author":"S Field","year":"2013","unstructured":"Field S, Davies J, Bishop DT, Newton-Bishop JA (2013) Vitamin D and melanoma. Dermatoendocrinol 5:121\u2013129. doi: 10.4161\/derm.25244","journal-title":"Dermatoendocrinol"},{"key":"305_CR11","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.chembiol.2013.12.016","volume":"21","author":"DD Bikle","year":"2014","unstructured":"Bikle DD (2014) Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol 21:319\u2013329. doi: 10.1016\/j.chembiol.2013.12.016","journal-title":"Chem Biol"},{"key":"305_CR12","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1152\/physrev.1998.78.4.1193","volume":"78","author":"G Jones","year":"1998","unstructured":"Jones G, Strugnell SA, DeLuca HF (1998) Current understanding of the molecular actions of vitamin D. Physiol Rev 78:1193\u20131231","journal-title":"Physiol Rev"},{"key":"305_CR13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.abb.2012.01.013","volume":"523","author":"J Zhu","year":"2012","unstructured":"Zhu J, DeLuca HF (2012) Vitamin D 25-hydroxylase\u2014four decades of searching, are we there yet? Arch Biochem Biophys 523:30\u201336. doi: 10.1016\/j.abb.2012.01.013","journal-title":"Arch Biochem Biophys"},{"key":"305_CR14","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/kisup.2011.30","volume":"1","author":"AS Dusso","year":"2011","unstructured":"Dusso AS (2011) Kidney disease and vitamin D levels: 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and VDR activation. Kidney Int Suppl 1:136\u2013141. doi: 10.1038\/kisup.2011.30","journal-title":"Kidney Int Suppl"},{"issue":"(Pt A)","key":"305_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jsbmb.2013.12.009","volume":"144","author":"JS Adams","year":"2014","unstructured":"Adams JS, Rafison B, Witzel S et al (2014) Regulation of the extrarenal CYP27B1-hydroxylase. J Steroid Biochem Mol Biol 144((Pt A)):22\u201327. doi: 10.1016\/j.jsbmb.2013.12.009","journal-title":"J Steroid Biochem Mol Biol"},{"key":"305_CR16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ecl.2010.02.002","volume":"39","author":"S Christakos","year":"2010","unstructured":"Christakos S, Ajibade DV, Dhawan P et al (2010) Vitamin D: metabolism. Endocrinol Metab Clin North Am 39:243\u2013253. doi: 10.1016\/j.ecl.2010.02.002 (table of contents)","journal-title":"Endocrinol Metab Clin North Am"},{"key":"305_CR17","doi-asserted-by":"publisher","first-page":"561214","DOI":"10.1155\/2014\/561214","volume":"2014","author":"I Bhan","year":"2014","unstructured":"Bhan I (2014) Vitamin D binding protein and bone health. Int J Endocrinol 2014:561214. doi: 10.1155\/2014\/561214","journal-title":"Int J Endocrinol"},{"key":"305_CR18","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1210\/jcem-61-5-969","volume":"61","author":"DD Bikle","year":"1985","unstructured":"Bikle DD, Siiteri PK, Ryzen E, Haddad JG (1985) Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels. J Clin Endocrinol Metab 61:969\u2013975. doi: 10.1210\/jcem-61-5-969","journal-title":"J Clin Endocrinol Metab"},{"key":"305_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.abb.2011.11.003","volume":"523","author":"G Jones","year":"2012","unstructured":"Jones G, Prosser DE, Kaufmann M (2012) 25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D. Arch Biochem Biophys 523:9\u201318. doi: 10.1016\/j.abb.2011.11.003","journal-title":"Arch Biochem Biophys"},{"key":"305_CR20","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.beem.2011.05.003","volume":"25","author":"HL Henry","year":"2011","unstructured":"Henry HL (2011) Regulation of vitamin D metabolism. Best Pract Res Clin Endocrinol Metab 25:531\u2013541. doi: 10.1016\/j.beem.2011.05.003","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"305_CR21","first-page":"53","volume":"36","author":"JW Ryan","year":"2015","unstructured":"Ryan JW, Anderson PH, Morris HA (2015) Pleiotropic activities of vitamin D receptors\u2014adequate activation for multiple health outcomes. Clin Biochem Rev 36:53\u201361","journal-title":"Clin Biochem Rev"},{"key":"305_CR22","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1042\/bj0310122","volume":"31","author":"R Nicolaysen","year":"1937","unstructured":"Nicolaysen R (1937) Studies upon the mode of action of vitamin D: the influence of vitamin D on the absorption of calcium and phosphorus in the rat. Biochem J 31:122\u2013129","journal-title":"Biochem J"},{"key":"305_CR23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1172\/JCI106823","volume":"51","author":"JB Puschett","year":"1972","unstructured":"Puschett JB, Moranz J, Kurnick WS (1972) Evidence for a direct action of cholecalciferol and 25-hydroxycholecalciferol on the renal transport of phosphate, sodium, and calcium. J Clin Invest 51:373\u2013385. doi: 10.1172\/JCI106823","journal-title":"J Clin Invest"},{"key":"305_CR24","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1172\/JCI45890","volume":"122","author":"L Lieben","year":"2012","unstructured":"Lieben L, Masuyama R, Torrekens S et al (2012) Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization. J Clin Invest 122:1803\u20131815. doi: 10.1172\/JCI45890","journal-title":"J Clin Invest"},{"key":"305_CR25","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.bone.2012.10.007","volume":"54","author":"L Lieben","year":"2013","unstructured":"Lieben L, Carmeliet G (2013) Vitamin D signaling in osteocytes: effects on bone and mineral homeostasis. Bone 54:237\u2013243. doi: 10.1016\/j.bone.2012.10.007","journal-title":"Bone"},{"key":"305_CR26","first-page":"E384","volume":"238","author":"BS Chertow","year":"1980","unstructured":"Chertow BS, Baker GR, Henry HL, Norman AW (1980) Effects of vitamin D metabolites on bovine parathyroid hormone release in vitro. Am J Physiol 238:E384\u2013E388","journal-title":"Am J Physiol"},{"key":"305_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11154-011-9199-8","volume":"13","author":"MR Haussler","year":"2012","unstructured":"Haussler MR, Whitfield GK, Kaneko I et al (2012) The role of vitamin D in the FGF23, klotho, and phosphate bone-kidney endocrine axis. Rev Endocr Metab Disord 13:57\u201369. doi: 10.1007\/s11154-011-9199-8","journal-title":"Rev Endocr Metab Disord"},{"key":"305_CR28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3343\/alm.2014.34.3.181","volume":"34","author":"HA Morris","year":"2014","unstructured":"Morris HA (2014) Vitamin D activities for health outcomes. Ann Lab Med 34:181\u2013186. doi: 10.3343\/alm.2014.34.3.181","journal-title":"Ann Lab Med"},{"issue":"Suppl 4","key":"305_CR29","doi-asserted-by":"publisher","first-page":"iv17","DOI":"10.1093\/ndt\/gfs534","volume":"27","author":"E Gonzalez-Parra","year":"2012","unstructured":"Gonzalez-Parra E, Rojas-Rivera J, Tu\u00f1\u00f3n J et al (2012) Vitamin D receptor activation and cardiovascular disease. Nephrol Dial Transplant 27(Suppl 4):iv17\u2013iv21. doi: 10.1093\/ndt\/gfs534","journal-title":"Nephrol Dial Transplant"},{"key":"305_CR30","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1440-1797.2006.00754.x","volume":"12","author":"GJ Elder","year":"2007","unstructured":"Elder GJ (2007) Vitamin D levels, bone turnover and bone mineral density show seasonal variation in patients with chronic kidney disease stage 5. Nephrol Carlton Vic 12:90\u201394. doi: 10.1111\/j.1440-1797.2006.00754.x","journal-title":"Nephrol Carlton Vic"},{"key":"305_CR31","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1161\/HYPERTENSIONAHA.107.087288","volume":"49","author":"JP Forman","year":"2007","unstructured":"Forman JP, Giovannucci E, Holmes MD et al (2007) Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49:1063\u20131069. doi: 10.1161\/HYPERTENSIONAHA.107.087288","journal-title":"Hypertension"},{"key":"305_CR32","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1161\/CIRCOUTCOMES.112.967604","volume":"5","author":"L Wang","year":"2012","unstructured":"Wang L, Song Y, Manson JE et al (2012) Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes 5:819\u2013829. doi: 10.1161\/CIRCOUTCOMES.112.967604","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"305_CR33","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1185\/03007995.2013.766162","volume":"29","author":"R Rizzoli","year":"2013","unstructured":"Rizzoli R, Boonen S, Brandi M-L et al (2013) Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Curr Med Res Opin 29:305\u2013313. doi: 10.1185\/03007995.2013.766162","journal-title":"Curr Med Res Opin"},{"key":"305_CR34","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.2337\/db08-0593","volume":"57","author":"NG Forouhi","year":"2008","unstructured":"Forouhi NG, Luan J, Cooper A et al (2008) Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990\u20132000. Diabetes 57:2619\u20132625. doi: 10.2337\/db08-0593","journal-title":"Diabetes"},{"key":"305_CR35","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1001\/archinternmed.2008.560","volume":"169","author":"AA Ginde","year":"2009","unstructured":"Ginde AA, Mansbach JM, Camargo CA (2009) Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 169:384\u2013390. doi: 10.1001\/archinternmed.2008.560","journal-title":"Arch Intern Med"},{"key":"305_CR36","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2174\/187152013804487407","volume":"13","author":"S Pilz","year":"2013","unstructured":"Pilz S, Kienreich K, Tomaschitz A et al (2013) Vitamin D and cancer mortality: systematic review of prospective epidemiological studies. Anticancer Agents Med Chem 13:107\u2013117","journal-title":"Anticancer Agents Med Chem"},{"key":"305_CR37","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3945\/ajcn.112.047712","volume":"97","author":"B Sch\u00f6ttker","year":"2013","unstructured":"Sch\u00f6ttker B, Haug U, Schomburg L et al (2013) Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. Am J Clin Nutr 97:782\u2013793. doi: 10.3945\/ajcn.112.047712","journal-title":"Am J Clin Nutr"},{"key":"305_CR38","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/ki.2008.501","volume":"75","author":"P Ravani","year":"2009","unstructured":"Ravani P, Malberti F, Tripepi G et al (2009) Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int 75:88\u201395. doi: 10.1038\/ki.2008.501","journal-title":"Kidney Int"},{"key":"305_CR39","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1053\/j.ajkd.2011.04.029","volume":"58","author":"P Ure\u00f1a-Torres","year":"2011","unstructured":"Ure\u00f1a-Torres P, Metzger M, Haymann JP et al (2011) Association of kidney function, vitamin D deficiency, and circulating markers of mineral and bone disorders in CKD. Am J Kidney Dis 58:544\u2013553. doi: 10.1053\/j.ajkd.2011.04.029","journal-title":"Am J Kidney Dis"},{"key":"305_CR40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1210\/jc.2010-2704","volume":"96","author":"AC Ross","year":"2011","unstructured":"Ross AC, Manson JE, Abrams SA et al (2011) The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know. J Clin Endocrinol Metab 96:53\u201358. doi: 10.1210\/jc.2010-2704","journal-title":"J Clin Endocrinol Metab"},{"key":"305_CR41","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1210\/jc.2011-0385","volume":"96","author":"MF Holick","year":"2011","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911\u20131930. doi: 10.1210\/jc.2011-0385","journal-title":"J Clin Endocrinol Metab"},{"key":"305_CR42","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s00198-010-1285-3","volume":"21","author":"B Dawson-Hughes","year":"2010","unstructured":"Dawson-Hughes B, Mithal A, Bonjour J-P et al (2010) IOF position statement: vitamin D recommendations for older adults. Osteoporos Int 21:1151\u20131154. doi: 10.1007\/s00198-010-1285-3","journal-title":"Osteoporos Int"},{"key":"305_CR43","first-page":"1","volume":"42","author":"K Nkf","year":"2003","unstructured":"Nkf K (2003) DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:1\u2013202","journal-title":"Am J Kidney Dis"},{"key":"305_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2009.188","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group","year":"2009","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. doi: 10.1038\/ki.2009.188","journal-title":"Kidney Int Suppl"},{"key":"305_CR45","first-page":"1","volume":"3","author":"KDIGO CKD Work Group","year":"2012","unstructured":"KDIGO CKD Work Group (2012) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3:1\u2013150","journal-title":"Kidney Int Suppl"},{"key":"305_CR46","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1093\/ndt\/gfq513","volume":"25","author":"DJA Goldsmith","year":"2010","unstructured":"Goldsmith DJA, Covic A, Fouque D et al (2010) Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement. Nephrol Dial Transplant 25:3823\u20133831. doi: 10.1093\/ndt\/gfq513","journal-title":"Nephrol Dial Transplant"},{"key":"305_CR47","unstructured":"Chronic kidney disease in adults: assessment and management | Guidance and guidelines | NICE; https:\/\/www.nice.org.uk\/guidance\/cg182 . Accessed 15 Dec 2015"},{"key":"305_CR48","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.3945\/ajcn.111.031070","volume":"95","author":"L Tripkovic","year":"2012","unstructured":"Tripkovic L, Lambert H, Hart K et al (2012) Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr 95:1357\u20131364. doi: 10.3945\/ajcn.111.031070","journal-title":"Am J Clin Nutr"},{"key":"305_CR49","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/ajcn\/84.4.694","volume":"84","author":"LA Houghton","year":"2006","unstructured":"Houghton LA, Vieth R (2006) The case against ergocalciferol (vitamin D2) as a vitamin supplement. Am J Clin Nutr 84:694\u2013697","journal-title":"Am J Clin Nutr"},{"key":"305_CR50","doi-asserted-by":"crossref","first-page":"9250","DOI":"10.1016\/S0021-9258(18)67647-1","volume":"261","author":"RL Horst","year":"1986","unstructured":"Horst RL, Reinhardt TA, Ramberg CF et al (1986) 24-Hydroxylation of 1,25-dihydroxyergocalciferol. An unambiguous deactivation process. J Biol Chem 261:9250\u20139256","journal-title":"J Biol Chem"},{"key":"305_CR51","doi-asserted-by":"publisher","first-page":"50","DOI":"10.2215\/CJN.03940510","volume":"6","author":"P Kandula","year":"2011","unstructured":"Kandula P, Dobre M, Schold JD et al (2011) Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol CJASN 6:50\u201362. doi: 10.2215\/CJN.03940510","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"305_CR52","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1053\/j.ajkd.2011.12.035","volume":"60","author":"SU Nigwekar","year":"2012","unstructured":"Nigwekar SU, Bhan I, Thadhani R (2012) Ergocalciferol and cholecalciferol in CKD. Am J Kidney Dis 60:139\u2013156. doi: 10.1053\/j.ajkd.2011.12.035","journal-title":"Am J Kidney Dis"},{"key":"305_CR53","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4158\/EP.14.1.10","volume":"14","author":"P Chandra","year":"2008","unstructured":"Chandra P, Binongo JNG, Ziegler TR et al (2008) Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study. Endocr Pract 14:10\u201317. doi: 10.4158\/EP.14.1.10","journal-title":"Endocr Pract"},{"key":"305_CR54","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1159\/000369939","volume":"40","author":"SM Sprague","year":"2014","unstructured":"Sprague SM, Silva AL, Al-Saghir F et al (2014) Modified-release calcifediol effectively controls secondary hyperparathyroidism associated with vitamin D insufficiency in chronic kidney disease. Am J Nephrol 40:535\u2013545. doi: 10.1159\/000369939","journal-title":"Am J Nephrol"},{"key":"305_CR55","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2215\/CJN.07131009","volume":"5","author":"SM Moe","year":"2010","unstructured":"Moe SM, Saifullah A, LaClair RE et al (2010) A randomized trial of cholecalciferol versus doxercalciferol for lowering parathyroid hormone in chronic kidney disease. Clin J Am Soc Nephrol CJASN 5:299\u2013306. doi: 10.2215\/CJN.07131009","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"305_CR56","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1053\/j.ajkd.2011.06.027","volume":"59","author":"CP Kovesdy","year":"2012","unstructured":"Kovesdy CP, Lu JL, Malakauskas SM et al (2012) Paricalcitol versus ergocalciferol for secondary hyperparathyroidism in CKD stages 3 and 4: a randomized controlled trial. Am J Kidney Dis 59:58\u201366. doi: 10.1053\/j.ajkd.2011.06.027","journal-title":"Am J Kidney Dis"},{"key":"305_CR57","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/ndt\/gft360","volume":"29","author":"P Molina","year":"2014","unstructured":"Molina P, G\u00f3rriz JL, Molina MD et al (2014) The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled study. Nephrol Dial Transplant 29:97\u2013109. doi: 10.1093\/ndt\/gft360","journal-title":"Nephrol Dial Transplant"},{"key":"305_CR58","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2147\/IJNRD.S90968","volume":"8","author":"A Cupisti","year":"2015","unstructured":"Cupisti A, Vigo V, Baronti ME et al (2015) Vitamin D status and cholecalciferol supplementation in chronic kidney disease patients: an Italian cohort report. Int J Nephrol Renov Dis 8:151\u2013157. doi: 10.2147\/IJNRD.S90968","journal-title":"Int J Nephrol Renov Dis"},{"key":"305_CR59","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1053\/j.ajkd.2008.09.020","volume":"53","author":"L Kooienga","year":"2009","unstructured":"Kooienga L, Fried L, Scragg R et al (2009) The effect of combined calcium and vitamin D3 supplementation on serum intact parathyroid hormone in moderate CKD. Am J Kidney Dis 53:408\u2013416. doi: 10.1053\/j.ajkd.2008.09.020","journal-title":"Am J Kidney Dis"},{"key":"305_CR60","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1093\/ndt\/gfs138","volume":"27","author":"P Marckmann","year":"2012","unstructured":"Marckmann P, Agerskov H, Thineshkumar S et al (2012) Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D. Nephrol Dial Transplant 27:3523\u20133531. doi: 10.1093\/ndt\/gfs138","journal-title":"Nephrol Dial Transplant"},{"key":"305_CR61","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3945\/ajcn.112.040642","volume":"96","author":"JA Alvarez","year":"2012","unstructured":"Alvarez JA, Law J, Coakley KE et al (2012) High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 96:672\u2013679. doi: 10.3945\/ajcn.112.040642","journal-title":"Am J Clin Nutr"},{"key":"305_CR62","doi-asserted-by":"publisher","first-page":"216","DOI":"10.2215\/CJN.04760511","volume":"7","author":"R Shroff","year":"2012","unstructured":"Shroff R, Wan M, Gullett A et al (2012) Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism: a randomized trial. Clin J Am Soc Nephrol CJASN 7:216\u2013223. doi: 10.2215\/CJN.04760511","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"305_CR63","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/j.1542-4758.2010.00472.x","volume":"14","author":"G Jean","year":"2010","unstructured":"Jean G, Vanel T, Terrat J-C, Chazot C (2010) Prevention of secondary hyperparathyroidism in hemodialysis patients: the key role of native vitamin D supplementation. Hemodial Int 14:486\u2013491. doi: 10.1111\/j.1542-4758.2010.00472.x","journal-title":"Hemodial Int"},{"key":"305_CR64","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1210\/jcem-67-5-929","volume":"67","author":"KP Nordal","year":"1988","unstructured":"Nordal KP, Dahl E (1988) Low dose calcitriol versus placebo in patients with predialysis chronic renal failure. J Clin Endocrinol Metab 67:929\u2013936. doi: 10.1210\/jcem-67-5-929","journal-title":"J Clin Endocrinol Metab"},{"key":"305_CR65","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/bmj.310.6976.358","volume":"310","author":"NA Hamdy","year":"1995","unstructured":"Hamdy NA, Kanis JA, Beneton MN et al (1995) Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure. BMJ 310:358\u2013363","journal-title":"BMJ"},{"key":"305_CR66","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2174\/15701611113119990024","volume":"12","author":"S Mazzaferro","year":"2014","unstructured":"Mazzaferro S, Goldsmith D, Larsson TE et al (2014) Vitamin D metabolites and\/or analogs: which D for which patient? Curr Vasc Pharmacol 12:339\u2013349","journal-title":"Curr Vasc Pharmacol"},{"key":"305_CR67","doi-asserted-by":"publisher","first-page":"864012","DOI":"10.1155\/2013\/864012","volume":"2013","author":"A Galassi","year":"2013","unstructured":"Galassi A, Bellasi A, Auricchio S et al (2013) Which vitamin D in CKD-MBD? The time of burning questions. BioMed Res Int 2013:864012. doi: 10.1155\/2013\/864012","journal-title":"BioMed Res Int"},{"key":"305_CR68","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1053\/j.ajkd.2005.10.007","volume":"47","author":"D Coyne","year":"2006","unstructured":"Coyne D, Acharya M, Qiu P et al (2006) Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD. Am J Kidney Dis 47:263\u2013276. doi: 10.1053\/j.ajkd.2005.10.007","journal-title":"Am J Kidney Dis"},{"key":"305_CR69","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.2215\/CJN.10661013","volume":"9","author":"DW Coyne","year":"2014","unstructured":"Coyne DW, Goldberg S, Faber M et al (2014) A randomized multicenter trial of paricalcitol versus calcitriol for secondary hyperparathyroidism in stages 3\u20134 CKD. Clin J Am Soc Nephrol CJASN 9:1620\u20131626. doi: 10.2215\/CJN.10661013","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"305_CR70","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1093\/ndt\/gft227","volume":"28","author":"DW Coyne","year":"2013","unstructured":"Coyne DW, Andress DL, Amdahl MJ et al (2013) Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: results of the VITAL study. Nephrol Dial Transplant 28:2260\u20132268. doi: 10.1093\/ndt\/gft227","journal-title":"Nephrol Dial Transplant"},{"key":"305_CR71","doi-asserted-by":"publisher","first-page":"201","DOI":"10.5414\/CN108306","volume":"83","author":"I Martinez-Fernandez","year":"2015","unstructured":"Martinez-Fernandez I, Saracho R (2015) Effects of paricalcitol on urinary calcium in patients with chronic kidney disease stages 2\u20134. Clin Nephrol 83:201\u2013207. doi: 10.5414\/CN108306","journal-title":"Clin Nephrol"},{"key":"305_CR72","doi-asserted-by":"publisher","first-page":"e61387","DOI":"10.1371\/journal.pone.0061387","volume":"8","author":"L Xu","year":"2013","unstructured":"Xu L, Wan X, Huang Z et al (2013) Impact of vitamin D on chronic kidney diseases in non-dialysis patients: a meta-analysis of randomized controlled trials. PLoS ONE 8:e61387. doi: 10.1371\/journal.pone.0061387","journal-title":"PLoS ONE"},{"key":"305_CR73","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1046\/j.1523-1755.2003.00029.x","volume":"63","author":"E Slatopolsky","year":"2003","unstructured":"Slatopolsky E, Cozzolino M, Lu Y et al (2003) Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia. Kidney Int 63:2020\u20132027. doi: 10.1046\/j.1523-1755.2003.00029.x","journal-title":"Kidney Int"},{"key":"305_CR74","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1053\/ajkd.2000.17667","volume":"36","author":"E Balint","year":"2000","unstructured":"Balint E, Marshall CF, Sprague SM (2000) Effect of the vitamin D analogues paricalcitol and calcitriol on bone mineral in vitro. Am J Kidney Dis 36:789\u2013796. doi: 10.1053\/ajkd.2000.17667","journal-title":"Am J Kidney Dis"},{"key":"305_CR75","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jsbmb.2005.07.007","volume":"98","author":"M Nakane","year":"2006","unstructured":"Nakane M, Fey TA, Dixon DB et al (2006) Differential effects of Vitamin D analogs on bone formation and resorption. J Steroid Biochem Mol Biol 98:72\u201377. doi: 10.1016\/j.jsbmb.2005.07.007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"305_CR76","doi-asserted-by":"publisher","first-page":"F1315","DOI":"10.1152\/ajprenal.00552.2009","volume":"298","author":"JL Finch","year":"2010","unstructured":"Finch JL, Tokumoto M, Nakamura H et al (2010) Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease. Am J Physiol Renal Physiol 298:F1315\u2013F1322. doi: 10.1152\/ajprenal.00552.2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"305_CR77","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1001\/jama.2012.16817","volume":"308","author":"SI Hallan","year":"2012","unstructured":"Hallan SI, Matsushita K, Sang Y et al (2012) Age and association of kidney measures with mortality and end-stage renal disease. JAMA 308:2349\u20132360. doi: 10.1001\/jama.2012.16817","journal-title":"JAMA"},{"key":"305_CR78","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/ki.2011.224","volume":"80","author":"MJ Kim","year":"2011","unstructured":"Kim MJ, Frankel AH, Donaldson M et al (2011) Oral cholecalciferol decreases albuminuria and urinary TGF-\u03b21 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition. Kidney Int 80:851\u2013860. doi: 10.1038\/ki.2011.224","journal-title":"Kidney Int"},{"key":"305_CR79","doi-asserted-by":"publisher","first-page":"e50510","DOI":"10.1371\/journal.pone.0050510","volume":"7","author":"Y Huang","year":"2012","unstructured":"Huang Y, Yu H, Lu J et al (2012) Oral supplementation with cholecalciferol 800\u00a0IU ameliorates albuminuria in Chinese type 2 diabetic patients with nephropathy. PLoS ONE 7:e50510. doi: 10.1371\/journal.pone.0050510","journal-title":"PLoS ONE"},{"key":"305_CR80","first-page":"374","volume":"18","author":"N Ahmadi","year":"2013","unstructured":"Ahmadi N, Mortazavi M, Iraj B, Askari G (2013) Whether vitamin D3 is effective in reducing proteinuria in type 2 diabetic patients? J Res Med Sci 18:374\u2013377","journal-title":"J Res Med Sci"},{"key":"305_CR81","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1159\/000157177","volume":"31","author":"A Oksa","year":"2008","unstructured":"Oksa A, Spustov\u00e1 V, Krivos\u00edkov\u00e1 Z et al (2008) Effects of long-term cholecalciferol supplementation on mineral metabolism and calciotropic hormones in chronic kidney disease. Kidney Blood Press Res 31:322\u2013329. doi: 10.1159\/000157177","journal-title":"Kidney Blood Press Res"},{"key":"305_CR82","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1681\/ASN.2013030203","volume":"24","author":"MH Borst de","year":"2013","unstructured":"de Borst MH, Hajhosseiny R, Tamez H et al (2013) Active vitamin D treatment for reduction of residual proteinuria: a systematic review. J Am Soc Nephrol JASN 24:1863\u20131871. doi: 10.1681\/ASN.2013030203","journal-title":"J Am Soc Nephrol JASN"},{"key":"305_CR83","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/S0140-6736(10)61032-X","volume":"376","author":"D Zeeuw de","year":"2010","unstructured":"de Zeeuw D, Agarwal R, Amdahl M et al (2010) Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet Lond Engl 376:1543\u20131551. doi: 10.1016\/S0140-6736(10)61032-X","journal-title":"Lancet Lond Engl"},{"issue":"Suppl 3","key":"305_CR84","first-page":"S41","volume":"95","author":"U Krairittichai","year":"2012","unstructured":"Krairittichai U, Mahannopkul R, Bunnag S (2012) An open label, randomized controlled study of oral calcitriol for the treatment of proteinuria in patients with diabetic kidney disease. J Med Assoc Thai 95(Suppl 3):S41\u2013S47","journal-title":"J Med Assoc Thai"},{"key":"305_CR85","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1053\/j.ajkd.2011.09.014","volume":"59","author":"L-J Liu","year":"2012","unstructured":"Liu L-J, Lv J-C, Shi S-F et al (2012) Oral calcitriol for reduction of proteinuria in patients with IgA nephropathy: a randomized controlled trial. Am J Kidney Dis 59:67\u201374. doi: 10.1053\/j.ajkd.2011.09.014","journal-title":"Am J Kidney Dis"},{"key":"305_CR86","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1111\/j.1523-1755.2005.00755.x","volume":"68","author":"R Agarwal","year":"2005","unstructured":"Agarwal R, Acharya M, Tian J et al (2005) Antiproteinuric effect of oral paricalcitol in chronic kidney disease. Kidney Int 68:2823\u20132828. doi: 10.1111\/j.1523-1755.2005.00755.x","journal-title":"Kidney Int"},{"key":"305_CR87","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1053\/j.ajkd.2009.04.036","volume":"54","author":"S Fishbane","year":"2009","unstructured":"Fishbane S, Chittineni H, Packman M et al (2009) Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial. Am J Kidney Dis 54:647\u2013652. doi: 10.1053\/j.ajkd.2009.04.036","journal-title":"Am J Kidney Dis"},{"key":"305_CR88","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1001\/jama.2012.120","volume":"307","author":"R Thadhani","year":"2012","unstructured":"Thadhani R, Appelbaum E, Pritchett Y et al (2012) Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. JAMA 307:674\u2013684. doi: 10.1001\/jama.2012.120","journal-title":"JAMA"},{"key":"305_CR89","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1093\/cvr\/cvr133","volume":"91","author":"S Bae","year":"2011","unstructured":"Bae S, Yalamarti B, Ke Q et al (2011) Preventing progression of cardiac hypertrophy and development of heart failure by paricalcitol therapy in rats. Cardiovasc Res 91:632\u2013639. doi: 10.1093\/cvr\/cvr133","journal-title":"Cardiovasc Res"},{"key":"305_CR90","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1172\/JCI118582","volume":"97","author":"J Wu","year":"1996","unstructured":"Wu J, Garami M, Cheng T, Gardner DG (1996) 1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes. J Clin Invest 97:1577\u20131588. doi: 10.1172\/JCI118582","journal-title":"J Clin Invest"},{"key":"305_CR91","doi-asserted-by":"publisher","first-page":"16810","DOI":"10.1073\/pnas.0611202104","volume":"104","author":"N Bodyak","year":"2007","unstructured":"Bodyak N, Ayus JC, Achinger S et al (2007) Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals. Proc Natl Acad Sci USA 104:16810\u201316815. doi: 10.1073\/pnas.0611202104","journal-title":"Proc Natl Acad Sci USA"},{"key":"305_CR92","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1681\/ASN.2013010103","volume":"25","author":"AY-M Wang","year":"2014","unstructured":"Wang AY-M, Fang F, Chan J et al (2014) Effect of paricalcitol on left ventricular mass and function in CKD\u2013the OPERA trial. J Am Soc Nephrol JASN 25:175\u2013186. doi: 10.1681\/ASN.2013010103","journal-title":"J Am Soc Nephrol JASN"},{"key":"305_CR93","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5414\/CNP74025","volume":"74","author":"PT Lac","year":"2010","unstructured":"Lac PT, Choi K, Liu I-A et al (2010) The effects of changing vitamin D levels on anemia in chronic kidney disease patients: a retrospective cohort review. Clin Nephrol 74:25\u201332","journal-title":"Clin Nephrol"},{"key":"305_CR94","doi-asserted-by":"publisher","first-page":"c373","DOI":"10.1159\/000321521","volume":"117","author":"Z Kiss","year":"2011","unstructured":"Kiss Z, Ambrus C, Almasi C et al (2011) Serum 25(OH)-cholecalciferol concentration is associated with hemoglobin level and erythropoietin resistance in patients on maintenance hemodialysis. Nephron Clin Pract 117:c373\u2013c378. doi: 10.1159\/000321521","journal-title":"Nephron Clin Pract"},{"key":"305_CR95","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5301\/JN.2010.1830","volume":"24","author":"VA Kumar","year":"2011","unstructured":"Kumar VA, Kujubu DA, Sim JJ et al (2011) Vitamin D supplementation and recombinant human erythropoietin utilization in vitamin D-deficient hemodialysis patients. J Nephrol 24:98\u2013105","journal-title":"J Nephrol"},{"key":"305_CR96","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1007\/s00467-013-2431-x","volume":"28","author":"P Rianthavorn","year":"2013","unstructured":"Rianthavorn P, Boonyapapong P (2013) Ergocalciferol decreases erythropoietin resistance in children with chronic kidney disease stage 5. Pediatr Nephrol Berl Ger 28:1261\u20131266. doi: 10.1007\/s00467-013-2431-x","journal-title":"Pediatr Nephrol Berl Ger"},{"key":"305_CR97","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jcte.2014.01.003","volume":"1","author":"SM Zughaier","year":"2014","unstructured":"Zughaier SM, Alvarez JA, Sloan JH et al (2014) The role of vitamin D in regulating the iron-hepcidin-ferroportin axis in monocytes. J Clin Transl Endocrinol 1:19\u201325. doi: 10.1016\/j.jcte.2014.01.003","journal-title":"J Clin Transl Endocrinol"},{"issue":"Suppl 1","key":"305_CR98","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1097\/01.ASN.0000093369.09194.12","volume":"15","author":"D Brancaccio","year":"2004","unstructured":"Brancaccio D, Cozzolino M, Gallieni M (2004) Hyperparathyroidism and anemia in uremic subjects: a combined therapeutic approach. J Am Soc Nephrol JASN 15(Suppl 1):S21\u2013S24","journal-title":"J Am Soc Nephrol JASN"},{"key":"305_CR99","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1126\/science.1104742","volume":"306","author":"E Nemeth","year":"2004","unstructured":"Nemeth E, Tuttle MS, Powelson J et al (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306:2090\u20132093. doi: 10.1126\/science.1104742","journal-title":"Science"},{"key":"305_CR100","doi-asserted-by":"publisher","first-page":"c121","DOI":"10.1093\/ndt\/14.5.1171","volume":"95","author":"FE Aucella","year":"2003","unstructured":"Aucella F, Scalzulli RP, Gatta G et al (2003) Calcitriol increases burst-forming unit-erythroid proliferation in chronic renal failure. A synergistic effect with r-HuEpo. Nephron Clin Pract 95:c121\u2013c127. doi: 10.1093\/ndt\/14.5.1171","journal-title":"Nephron Clin Pract"},{"key":"305_CR101","doi-asserted-by":"publisher","first-page":"e0118174","DOI":"10.1371\/journal.pone.0118174","volume":"10","author":"E Riccio","year":"2015","unstructured":"Riccio E, Sabbatini M, Bruzzese D et al (2015) Effect of paricalcitol vs calcitriol on hemoglobin levels in chronic kidney disease patients: a randomized trial. PLoS ONE 10:e0118174. doi: 10.1371\/journal.pone.0118174","journal-title":"PLoS ONE"},{"key":"305_CR102","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/ckj\/sfu122","volume":"8","author":"MC Mann","year":"2015","unstructured":"Mann MC, Hobbs AJ, Hemmelgarn BR et al (2015) Effect of oral vitamin D analogs on mortality and cardiovascular outcomes among adults with chronic kidney disease: a meta-analysis. Clin Kidney J 8:41\u201348. doi: 10.1093\/ckj\/sfu122","journal-title":"Clin Kidney J"},{"key":"305_CR103","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/ckj\/sfu135","volume":"8","author":"LF Morrone","year":"2015","unstructured":"Morrone LF, Cozzolino M (2015) The beneficial impact of vitamin D treatment in CKD patients: what\u2019s next? Clin Kidney J 8:38\u201340. doi: 10.1093\/ckj\/sfu135","journal-title":"Clin Kidney J"},{"key":"305_CR104","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/ndt\/gfp470","volume":"25","author":"J Almirall","year":"2010","unstructured":"Almirall J, Vaqueiro M, Bar\u00e9 ML, Anton E (2010) Association of low serum 25-hydroxyvitamin D levels and high arterial blood pressure in the elderly. Nephrol Dial Transplant 25:503\u2013509. doi: 10.1093\/ndt\/gfp470","journal-title":"Nephrol Dial Transplant"},{"key":"305_CR105","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1159\/000063106","volume":"20","author":"A Argil\u00e9s","year":"2002","unstructured":"Argil\u00e9s A, Lorho R, Servel M-F et al (2002) Blood pressure is correlated with vitamin D(3) serum levels in dialysis patients. Blood Purif 20:370\u2013375. doi: 10.1159\/000063106","journal-title":"Blood Purif"},{"key":"305_CR106","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(05)60827-6","volume":"352","author":"R Krause","year":"1998","unstructured":"Krause R, B\u00fchring M, Hopfenm\u00fcller W et al (1998) Ultraviolet B and blood pressure. Lancet Lond Engl 352:709\u2013710. doi: 10.1016\/S0140-6736(05)60827-6","journal-title":"Lancet Lond Engl"},{"key":"305_CR107","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1093\/ndt\/gfq606","volume":"26","author":"C Drechsler","year":"2011","unstructured":"Drechsler C, Verduijn M, Pilz S et al (2011) Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study. Nephrol Dial Transplant 26:1024\u20131032. doi: 10.1093\/ndt\/gfq606","journal-title":"Nephrol Dial Transplant"},{"key":"305_CR108","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/ajcn\/87.6.1631","volume":"87","author":"AY-M Wang","year":"2008","unstructured":"Wang AY-M, Lam CW-K, Sanderson JE et al (2008) Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study. Am J Clin Nutr 87:1631\u20131638","journal-title":"Am J Clin Nutr"},{"key":"305_CR109","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1053\/j.jrn.2011.07.001","volume":"22","author":"S Bucharles","year":"2012","unstructured":"Bucharles S, Barberato SH, Stinghen AEM et al (2012) Impact of cholecalciferol treatment on biomarkers of inflammation and myocardial structure in hemodialysis patients without hyperparathyroidism. J Ren Nutr 22:284\u2013291. doi: 10.1053\/j.jrn.2011.07.001","journal-title":"J Ren Nutr"},{"key":"305_CR110","doi-asserted-by":"publisher","first-page":"905","DOI":"10.2215\/CJN.06510909","volume":"5","author":"PJ Matias","year":"2010","unstructured":"Matias PJ, Jorge C, Ferreira C et al (2010) Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters. Clin J Am Soc Nephrol CJASN 5:905\u2013911. doi: 10.2215\/CJN.06510909","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"305_CR111","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1681\/ASN.2009040451","volume":"21","author":"JR Stubbs","year":"2010","unstructured":"Stubbs JR, Idiculla A, Slusser J et al (2010) Cholecalciferol supplementation alters calcitriol-responsive monocyte proteins and decreases inflammatory cytokines in ESRD. J Am Soc Nephrol JASN 21:353\u2013361. doi: 10.1681\/ASN.2009040451","journal-title":"J Am Soc Nephrol JASN"},{"key":"305_CR112","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrneph.2011.53","volume":"7","author":"DJA Goldsmith","year":"2011","unstructured":"Goldsmith DJA, Cunningham J (2011) Mineral metabolism and vitamin D in chronic kidney disease\u2013more questions than answers. Nat Rev Nephrol 7:341\u2013346. doi: 10.1038\/nrneph.2011.53","journal-title":"Nat Rev Nephrol"},{"key":"305_CR113","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/hdi.12209","volume":"19","author":"E Valle Del","year":"2015","unstructured":"Del Valle E, Negri AL, Fradinger E et al (2015) Weekly high-dose ergocalciferol to correct vitamin D deficiency\/insufficiency in hemodialysis patients: a pilot trial. Hemodial Int 19:60\u201365. doi: 10.1111\/hdi.12209","journal-title":"Hemodial Int"},{"key":"305_CR114","doi-asserted-by":"publisher","first-page":"358","DOI":"10.2215\/CJN.04040411","volume":"7","author":"ML Melamed","year":"2012","unstructured":"Melamed ML, Thadhani RI (2012) Vitamin D therapy in chronic kidney disease and end stage renal disease. Clin J Am Soc Nephrol CJASN 7:358\u2013365. doi: 10.2215\/CJN.04040411","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"305_CR115","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.semnephrol.2014.10.002","volume":"34","author":"DJA Goldsmith","year":"2014","unstructured":"Goldsmith DJA, Massy ZA, Brandenburg V (2014) The uses and abuses of Vitamin D compounds in chronic kidney disease-mineral bone disease (CKD-MBD). Semin Nephrol 34:660\u2013668. doi: 10.1016\/j.semnephrol.2014.10.002","journal-title":"Semin Nephrol"},{"key":"305_CR116","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/sj.ki.5002451","volume":"72","author":"M Wolf","year":"2007","unstructured":"Wolf M, Shah A, Gutierrez O et al (2007) Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 72:1004\u20131013. doi: 10.1038\/sj.ki.5002451","journal-title":"Kidney Int"},{"key":"305_CR117","doi-asserted-by":"publisher","first-page":"c204","DOI":"10.1159\/000321507","volume":"118","author":"G Jean","year":"2011","unstructured":"Jean G, Lataillade D, Genet L et al (2011) Impact of hypovitaminosis D and alfacalcidol therapy on survival of hemodialysis patients: results from the French ARNOS study. Nephron Clin Pract 118:c204\u2013c210. doi: 10.1159\/000321507","journal-title":"Nephron Clin Pract"},{"key":"305_CR118","first-page":"391","volume":"32","author":"R Krause","year":"2012","unstructured":"Krause R, Schober-Halstenberg H-J, Edenharter G et al (2012) Vitamin D status and mortality of German hemodialysis patients. Anticancer Res 32:391\u2013395","journal-title":"Anticancer Res"},{"key":"305_CR119","doi-asserted-by":"publisher","first-page":"152","DOI":"10.5301\/jn.5000123","volume":"26","author":"M Daroux","year":"2013","unstructured":"Daroux M, Shenouda M, Bacri J-L et al (2013) Vitamin D2 versus vitamin D3 supplementation in hemodialysis patients: a comparative pilot study. J Nephrol 26:152\u2013157. doi: 10.5301\/jn.5000123","journal-title":"J Nephrol"},{"key":"305_CR120","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.2215\/CJN.12761211","volume":"7","author":"LAG Armas","year":"2012","unstructured":"Armas LAG, Andukuri R, Barger-Lux J et al (2012) 25-Hydroxyvitamin D response to cholecalciferol supplementation in hemodialysis. Clin J Am Soc Nephrol CJASN 7:1428\u20131434. doi: 10.2215\/CJN.12761211","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"305_CR121","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3945\/ajcn.111.025502","volume":"95","author":"H Wasse","year":"2012","unstructured":"Wasse H, Huang R, Long Q et al (2012) Efficacy and safety of a short course of very-high-dose cholecalciferol in hemodialysis. Am J Clin Nutr 95:522\u2013528. doi: 10.3945\/ajcn.111.025502","journal-title":"Am J Clin Nutr"},{"key":"305_CR122","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1093\/ndt\/gft001","volume":"28","author":"P Delanaye","year":"2013","unstructured":"Delanaye P, Weekers L, Warling X et al (2013) Cholecalciferol in haemodialysis patients: a randomized, double-blind, proof-of-concept and safety study. Nephrol Dial Transplant 28:1779\u20131786. doi: 10.1093\/ndt\/gft001","journal-title":"Nephrol Dial Transplant"},{"key":"305_CR123","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.2215\/CJN.02840312","volume":"8","author":"NA Hewitt","year":"2013","unstructured":"Hewitt NA, O\u2019Connor AA, O\u2019Shaughnessy DV, Elder GJ (2013) Effects of cholecalciferol on functional, biochemical, vascular, and quality of life outcomes in hemodialysis patients. Clin J Am Soc Nephrol CJASN 8:1143\u20131149. doi: 10.2215\/CJN.02840312","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"305_CR124","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1053\/j.ajkd.2014.04.020","volume":"64","author":"A Massart","year":"2014","unstructured":"Massart A, Debelle FD, Racap\u00e9 J et al (2014) Biochemical parameters after cholecalciferol repletion in hemodialysis: results From the VitaDial randomized trial. Am J Kidney Dis 64:696\u2013705. doi: 10.1053\/j.ajkd.2014.04.020","journal-title":"Am J Kidney Dis"},{"key":"305_CR125","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2215\/CJN.06910714","volume":"10","author":"I Bhan","year":"2015","unstructured":"Bhan I, Dobens D, Tamez H et al (2015) Nutritional vitamin D supplementation in dialysis: a randomized trial. Clin J Am Soc Nephrol CJASN 10:611\u2013619. doi: 10.2215\/CJN.06910714","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"305_CR126","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014101009","author":"M Chonchol","year":"2015","unstructured":"Chonchol M, Greene T, Zhang Y et al (2015) Low Vitamin D and High Fibroblast Growth Factor 23 Serum Levels Associate with Infectious and Cardiac Deaths in the HEMO Study. J Am Soc Nephrol JASN. doi: 10.1681\/ASN.2014101009","journal-title":"J Am Soc Nephrol JASN"},{"key":"305_CR127","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015040468","author":"DC Miskulin","year":"2015","unstructured":"Miskulin DC, Majchrzak K, Tighiouart H et al (2015) Ergocalciferol supplementation in hemodialysis patients with vitamin D deficiency: a randomized clinical trial. J Am Soc Nephrol JASN. doi: 10.1681\/ASN.2015040468","journal-title":"J Am Soc Nephrol JASN"},{"key":"305_CR128","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/1471-2369-14-199","volume":"14","author":"Z Zheng","year":"2013","unstructured":"Zheng Z, Shi H, Jia J et al (2013) Vitamin D supplementation and mortality risk in chronic kidney disease: a meta-analysis of 20 observational studies. BMC Nephrol 14:199. doi: 10.1186\/1471-2369-14-199","journal-title":"BMC Nephrol"},{"key":"305_CR129","doi-asserted-by":"publisher","first-page":"e864012","DOI":"10.1155\/2013\/864012","volume":"2013","author":"A Galassi","year":"2013","unstructured":"Galassi A, Bellasi A, Auricchio S et al (2013) Which vitamin D in CKD-MBD? The time of burning questions. BioMed Res Int 2013:e864012. doi: 10.1155\/2013\/864012","journal-title":"BioMed Res Int"},{"key":"305_CR130","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1056\/NEJMoa022536","volume":"349","author":"M Teng","year":"2003","unstructured":"Teng M, Wolf M, Lowrie E et al (2003) Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 349:446\u2013456. doi: 10.1056\/NEJMoa022536","journal-title":"N Engl J Med"},{"key":"305_CR131","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1681\/ASN.2004070573","volume":"16","author":"M Teng","year":"2005","unstructured":"Teng M, Wolf M, Ofsthun MN et al (2005) Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol JASN 16:1115\u20131125. doi: 10.1681\/ASN.2004070573","journal-title":"J Am Soc Nephrol JASN"},{"key":"305_CR132","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12882-015-0006-8","volume":"16","author":"P Messa","year":"2015","unstructured":"Messa P, Cozzolino M, Brancaccio D et al (2015) Effect of VDRA on survival in incident hemodialysis patients: results of the FARO-2 observational study. BMC Nephrol 16:11. doi: 10.1186\/s12882-015-0006-8","journal-title":"BMC Nephrol"},{"key":"305_CR133","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1038\/ki.2008.35","volume":"73","author":"CP Kovesdy","year":"2008","unstructured":"Kovesdy CP, Kalantar-Zadeh K (2008) Vitamin D receptor activation and survival in chronic kidney disease. Kidney Int 73:1355\u20131363. doi: 10.1038\/ki.2008.35","journal-title":"Kidney Int"},{"key":"305_CR134","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1093\/ndt\/gfn592","volume":"24","author":"F Tentori","year":"2009","unstructured":"Tentori F, Albert JM, Young EW et al (2009) The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant 24:963\u2013972. doi: 10.1093\/ndt\/gfn592","journal-title":"Nephrol Dial Transplant"},{"key":"305_CR135","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000325454","volume":"32","author":"D Brancaccio","year":"2011","unstructured":"Brancaccio D, Cozzolino M, Cannella G et al (2011) Secondary hyperparathyroidism in chronic dialysis patients: results of the Italian FARO survey on treatment and mortality. Blood Purif 32:124\u2013132. doi: 10.1159\/000325454","journal-title":"Blood Purif"},{"key":"305_CR136","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1038\/sj.ki.5001868","volume":"70","author":"F Tentori","year":"2006","unstructured":"Tentori F, Hunt WC, Stidley CA et al (2006) Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int 70:1858\u20131865. doi: 10.1038\/sj.ki.5001868","journal-title":"Kidney Int"},{"key":"305_CR137","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1210\/jc.2014-3012","volume":"100","author":"CA Keyzer","year":"2015","unstructured":"Keyzer CA, Riphagen IJ, Joosten MM et al (2015) Associations of 25(OH) and 1,25(OH)2 vitamin D with long-term outcomes in stable renal transplant recipients. J Clin Endocrinol Metab 100:81\u201389. doi: 10.1210\/jc.2014-3012","journal-title":"J Clin Endocrinol Metab"},{"key":"305_CR138","doi-asserted-by":"publisher","first-page":"F8","DOI":"10.1152\/ajprenal.00336.2004","volume":"289","author":"AS Dusso","year":"2005","unstructured":"Dusso AS, Brown AJ, Slatopolsky E (2005) Vitamin D. Am J Physiol Renal Physiol 289:F8\u201328. doi: 10.1152\/ajprenal.00336.2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"305_CR139","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1053\/j.ajkd.2012.07.022","volume":"61","author":"HM Alshayeb","year":"2013","unstructured":"Alshayeb HM, Josephson MA, Sprague SM (2013) CKD-mineral and bone disorder management in kidney transplant recipients. Am J Kidney Dis 61:310\u2013325. doi: 10.1053\/j.ajkd.2012.07.022","journal-title":"Am J Kidney Dis"},{"key":"305_CR140","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1097\/TP.0b013e3181613fb5","volume":"85","author":"SS Tripathi","year":"2008","unstructured":"Tripathi SS, Gibney EM, Gehr TWB et al (2008) High prevalence of vitamin D deficiency in African American kidney transplant recipients. Transplantation 85:767\u2013770. doi: 10.1097\/TP.0b013e3181613fb5","journal-title":"Transplantation"},{"key":"305_CR141","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1210\/jc.2005-0547","volume":"91","author":"K Querings","year":"2006","unstructured":"Querings K, Girndt M, Geisel J et al (2006) 25-Hydroxyvitamin D deficiency in renal transplant recipients. J Clin Endocrinol Metab 91:526\u2013529. doi: 10.1210\/jc.2005-0547","journal-title":"J Clin Endocrinol Metab"},{"key":"305_CR142","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1681\/ASN.2012060614","volume":"24","author":"F Bienaim\u00e9","year":"2013","unstructured":"Bienaim\u00e9 F, Girard D, Anglicheau D et al (2013) Vitamin D status and outcomes after renal transplantation. J Am Soc Nephrol JASN 24:831\u2013841. doi: 10.1681\/ASN.2012060614","journal-title":"J Am Soc Nephrol JASN"},{"key":"305_CR143","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/MNM.0000000000000265","volume":"36","author":"X Barros","year":"2015","unstructured":"Barros X, Fuster D, Rodr\u00edguez N et al (2015) Rapid calcitriol increase and persistent calcidiol insufficiency in the first 6\u00a0months after kidney transplantation. Nucl Med Commun 36:489\u2013493. doi: 10.1097\/MNM.0000000000000265","journal-title":"Nucl Med Commun"},{"key":"305_CR144","doi-asserted-by":"publisher","first-page":"379082","DOI":"10.1155\/2009\/379082","volume":"2009","author":"D Economidou","year":"2009","unstructured":"Economidou D, Dovas S, Papagianni A et al (2009) FGF-23 levels before and after renal transplantation. J Transplant 2009:379082. doi: 10.1155\/2009\/379082","journal-title":"J Transplant"},{"key":"305_CR145","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.2215\/CJN.01310308","volume":"3","author":"P Evenepoel","year":"2008","unstructured":"Evenepoel P, Meijers BKI, de Jonge H et al (2008) Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation. Clin J Am Soc Nephrol CJASN 3:1829\u20131836. doi: 10.2215\/CJN.01310308","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"305_CR146","doi-asserted-by":"publisher","first-page":"4227","DOI":"10.1093\/ndt\/gfs409","volume":"27","author":"AI S\u00e1nchez Fructuoso","year":"2012","unstructured":"S\u00e1nchez Fructuoso AI, Maestro ML, P\u00e9rez-Flores I et al (2012) Serum level of fibroblast growth factor 23 in maintenance renal transplant patients. Nephrol Dial Transplant 27:4227\u20134235. doi: 10.1093\/ndt\/gfs409","journal-title":"Nephrol Dial Transplant"},{"key":"305_CR147","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.5301\/jn.5000102","volume":"25","author":"S Mazzaferro","year":"2012","unstructured":"Mazzaferro S, Pasquali M, Pugliese F et al (2012) Distinct impact of vitamin D insufficiency on calcitriol levels in chronic renal failure and renal transplant patients: a role for FGF23. J Nephrol 25:1108\u20131118. doi: 10.5301\/jn.5000102","journal-title":"J Nephrol"},{"key":"305_CR148","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1016\/j.transproceed.2012.09.070","volume":"44","author":"AI S\u00e1nchez Fructuoso","year":"2012","unstructured":"S\u00e1nchez Fructuoso AI, Maestro ML, Calvo N et al (2012) Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation. Transplant Proc 44:2551\u20132554. doi: 10.1016\/j.transproceed.2012.09.070","journal-title":"Transplant Proc"},{"key":"305_CR149","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1677\/joe.0.1640339","volume":"164","author":"N Akeno","year":"2000","unstructured":"Akeno N, Matsunuma A, Maeda T et al (2000) Regulation of vitamin D-1alpha-hydroxylase and -24-hydroxylase expression by dexamethasone in mouse kidney. J Endocrinol 164:339\u2013348","journal-title":"J Endocrinol"},{"key":"305_CR150","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/TP.0b013e3182985468","volume":"96","author":"CL Neves","year":"2013","unstructured":"Neves CL, dos Reis LM, Batista DG et al (2013) Persistence of bone and mineral disorders 2\u00a0years after successful kidney transplantation. Transplantation 96:290\u2013296. doi: 10.1097\/TP.0b013e3182985468","journal-title":"Transplantation"},{"key":"305_CR151","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/13102818.2014.995415","volume":"29","author":"JJ Filipov","year":"2015","unstructured":"Filipov JJ, Zlatkov BK, Dimitrov EP, Svinarov D (2015) Relationship between vitamin D status and immunosuppressive therapy in kidney transplant recipients. Biotechnol Biotechnol Equip 29:331\u2013335. doi: 10.1080\/13102818.2014.995415","journal-title":"Biotechnol Biotechnol Equip"},{"key":"305_CR152","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000328874","volume":"34","author":"C-T Lee","year":"2011","unstructured":"Lee C-T, Ng H-Y, Lien Y-H et al (2011) Effects of cyclosporine, tacrolimus and rapamycin on renal calcium transport and vitamin D metabolism. Am J Nephrol 34:87\u201394. doi: 10.1159\/000328874","journal-title":"Am J Nephrol"},{"key":"305_CR153","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1093\/ndt\/gfr214","volume":"26","author":"R Westenfeld","year":"2011","unstructured":"Westenfeld R, Schlieper G, W\u00f6ltje M et al (2011) Impact of sirolimus, tacrolimus and mycophenolate mofetil on osteoclastogenesis\u2014implications for post-transplantation bone disease. Nephrol Dial Transplant 26:4115\u20134123. doi: 10.1093\/ndt\/gfr214","journal-title":"Nephrol Dial Transplant"},{"key":"305_CR154","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jsbmb.2012.08.008","volume":"136","author":"PH Anderson","year":"2013","unstructured":"Anderson PH, Lam NN, Turner AG et al (2013) The pleiotropic effects of vitamin D in bone. J Steroid Biochem Mol Biol 136:190\u2013194. doi: 10.1016\/j.jsbmb.2012.08.008","journal-title":"J Steroid Biochem Mol Biol"},{"key":"305_CR155","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1097\/01.TP.0000131990.13277.28","volume":"77","author":"VM Brandenburg","year":"2004","unstructured":"Brandenburg VM, Politt D, Ketteler M et al (2004) Early rapid loss followed by long-term consolidation characterizes the development of lumbar bone mineral density after kidney transplantation. Transplantation 77:1566\u20131571","journal-title":"Transplantation"},{"issue":"Suppl 2","key":"305_CR156","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1365-2362.2006.01662.x","volume":"36","author":"K Kodras","year":"2006","unstructured":"Kodras K, Haas M (2006) Effect of kidney transplantation on bone. Eur J Clin Invest 36(Suppl 2):63\u201375. doi: 10.1111\/j.1365-2362.2006.01662.x","journal-title":"Eur J Clin Invest"},{"key":"305_CR157","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1053\/ajkd.2000.8289","volume":"36","author":"RG Carlini","year":"2000","unstructured":"Carlini RG, Rojas E, Weisinger JR et al (2000) Bone disease in patients with long-term renal transplantation and normal renal function. Am J Kidney Dis 36:160\u2013166. doi: 10.1053\/ajkd.2000.8289","journal-title":"Am J Kidney Dis"},{"key":"305_CR158","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1001\/jama.288.23.3014","volume":"288","author":"AM Ball","year":"2002","unstructured":"Ball AM, Gillen DL, Sherrard D et al (2002) Risk of hip fracture among dialysis and renal transplant recipients. JAMA 288:3014\u20133018","journal-title":"JAMA"},{"key":"305_CR159","first-page":"190","volume":"17","author":"VM Brandenburg","year":"2004","unstructured":"Brandenburg VM, Westenfeld R, Ketteler M (2004) The fate of bone after renal transplantation. J Nephrol 17:190\u2013204","journal-title":"J Nephrol"},{"key":"305_CR160","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1111\/j.1600-6143.2007.01950.x","volume":"7","author":"K Borchhardt","year":"2007","unstructured":"Borchhardt K, Sulzbacher I, Benesch T et al (2007) Low-turnover bone disease in hypercalcemic hyperparathyroidism after kidney transplantation. Am J Transplant 7:2515\u20132521. doi: 10.1111\/j.1600-6143.2007.01950.x","journal-title":"Am J Transplant"},{"key":"305_CR161","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/j.1432-2277.2005.00163.x","volume":"18","author":"JM Campistol","year":"2005","unstructured":"Campistol JM, Holt DW, Epstein S et al (2005) Bone metabolism in renal transplant patients treated with cyclosporine or sirolimus. Transpl Int 18:1028\u20131035. doi: 10.1111\/j.1432-2277.2005.00163.x","journal-title":"Transpl Int"},{"key":"305_CR162","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/TP.0b013e3181ff8754","volume":"91","author":"J Kahwaji","year":"2011","unstructured":"Kahwaji J, Bunnapradist S, Hsu J-W et al (2011) Cause of death with graft function among renal transplant recipients in an integrated healthcare system. Transplantation 91:225\u2013230. doi: 10.1097\/TP.0b013e3181ff8754","journal-title":"Transplantation"},{"issue":"Suppl 4","key":"305_CR163","doi-asserted-by":"publisher","first-page":"iv47","DOI":"10.1093\/ndt\/gfs508","volume":"27","author":"R Marc\u00e9n","year":"2012","unstructured":"Marc\u00e9n R, Jimenez S, Fern\u00e1ndez-Rodriguez A et al (2012) Are low levels of 25-hydroxyvitamin D a risk factor for cardiovascular diseases or malignancies in renal transplantation? Nephrol Dial Transplant 27(Suppl 4):iv47\u2013iv52. doi: 10.1093\/ndt\/gfs508","journal-title":"Nephrol Dial Transplant"},{"key":"305_CR164","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1159\/000346711","volume":"37","author":"MI Yilmaz","year":"2013","unstructured":"Yilmaz MI, Sonmez A, Saglam M et al (2013) Longitudinal analysis of vascular function and biomarkers of metabolic bone disorders before and after renal transplantation. Am J Nephrol 37:126\u2013134. doi: 10.1159\/000346711","journal-title":"Am J Nephrol"},{"key":"305_CR165","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1210\/jc.2013-2421","volume":"99","author":"Y Obi","year":"2014","unstructured":"Obi Y, Hamano T, Ichimaru N et al (2014) Vitamin D deficiency predicts decline in kidney allograft function: a prospective cohort study. J Clin Endocrinol Metab 99:527\u2013535. doi: 10.1210\/jc.2013-2421","journal-title":"J Clin Endocrinol Metab"},{"key":"305_CR166","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1681\/ASN.2008091005","volume":"20","author":"H Amer","year":"2009","unstructured":"Amer H, Cosio FG (2009) Significance and management of proteinuria in kidney transplant recipients. J Am Soc Nephrol JASN 20:2490\u20132492. doi: 10.1681\/ASN.2008091005","journal-title":"J Am Soc Nephrol JASN"},{"key":"305_CR167","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.TP.0000149322.70295.A5","volume":"79","author":"KM Wissing","year":"2005","unstructured":"Wissing KM, Broeders N, Moreno-Reyes R et al (2005) A controlled study of vitamin D3 to prevent bone loss in renal-transplant patients receiving low doses of steroids. Transplantation 79:108\u2013115","journal-title":"Transplantation"},{"key":"305_CR168","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/ki.2008.549","volume":"75","author":"M Courbebaisse","year":"2009","unstructured":"Courbebaisse M, Thervet E, Souberbielle JC et al (2009) Effects of vitamin D supplementation on the calcium-phosphate balance in renal transplant patients. Kidney Int 75:646\u2013651. doi: 10.1038\/ki.2008.549","journal-title":"Kidney Int"},{"key":"305_CR169","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1111\/j.1600-6143.2007.01978.x","volume":"7","author":"A Stavroulopoulos","year":"2007","unstructured":"Stavroulopoulos A, Cassidy MJD, Porter CJ et al (2007) Vitamin D status in renal transplant recipients. Am J Transplant 7:2546\u20132552. doi: 10.1111\/j.1600-6143.2007.01978.x","journal-title":"Am J Transplant"},{"key":"305_CR170","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0272-6386(00)70331-3","volume":"35","author":"AM Cueto-Manzano","year":"2000","unstructured":"Cueto-Manzano AM, Konel S, Freemont AJ et al (2000) Effect of 1,25-dihydroxyvitamin D3 and calcium carbonate on bone loss associated with long-term renal transplantation. Am J Kidney Dis 35:227\u2013236","journal-title":"Am J Kidney Dis"},{"key":"305_CR171","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/j.1523-1755.2004.00432.x","volume":"65","author":"A Torres","year":"2004","unstructured":"Torres A, Garc\u00eda S, G\u00f3mez A et al (2004) Treatment with intermittent calcitriol and calcium reduces bone loss after renal transplantation. Kidney Int 65:705\u2013712. doi: 10.1111\/j.1523-1755.2004.00432.x","journal-title":"Kidney Int"},{"key":"305_CR172","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2215\/CJN.03770609","volume":"5","author":"R Mainra","year":"2010","unstructured":"Mainra R, Elder GJ (2010) Individualized therapy to prevent bone mineral density loss after kidney and kidney-pancreas transplantation. Clin J Am Soc Nephrol CJASN 5:117\u2013124. doi: 10.2215\/CJN.03770609","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"305_CR173","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1097\/TP.0b013e3182855565","volume":"95","author":"E Gonzalez","year":"2013","unstructured":"Gonzalez E, Rojas-Rivera J, Polanco N et al (2013) Effects of oral paricalcitol on secondary hyperparathyroidism and proteinuria of kidney transplant patients. Transplantation 95:e49\u2013e52. doi: 10.1097\/TP.0b013e3182855565","journal-title":"Transplantation"},{"key":"305_CR174","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1111\/ajt.12227","volume":"13","author":"H Amer","year":"2013","unstructured":"Amer H, Griffin MD, Stegall MD et al (2013) Oral paricalcitol reduces the prevalence of posttransplant hyperparathyroidism: results of an open label randomized trial. Am J Transplant 13:1576\u20131585. doi: 10.1111\/ajt.12227","journal-title":"Am J Transplant"},{"key":"305_CR175","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1681\/ASN.2013111185","volume":"26","author":"M Trillini","year":"2015","unstructured":"Trillini M, Cortinovis M, Ruggenenti P et al (2015) Paricalcitol for secondary hyperparathyroidism in renal transplantation. J Am Soc Nephrol JASN 26:1205\u20131214. doi: 10.1681\/ASN.2013111185","journal-title":"J Am Soc Nephrol JASN"},{"key":"305_CR176","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/TP.0b013e318200ba37","volume":"91","author":"M Courbebaisse","year":"2011","unstructured":"Courbebaisse M, Xu-Dubois Y-C, Thervet E et al (2011) Cholecalciferol supplementation does not protect against renal allograft structural and functional deterioration: a retrospective study. Transplantation 91:207\u2013212. doi: 10.1097\/TP.0b013e318200ba37","journal-title":"Transplantation"},{"key":"305_CR177","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1186\/1745-6215-15-430","volume":"15","author":"M Courbebaisse","year":"2014","unstructured":"Courbebaisse M, Alberti C, Colas S et al (2014) VITamin D supplementation in renAL transplant recipients (VITALE): a prospective, multicentre, double-blind, randomized trial of vitamin D estimating the benefit and safety of vitamin D3 treatment at a dose of 100,000 UI compared with a dose of 12,000 UI in renal transplant recipients: study protocol for a double-blind, randomized, controlled trial. Trials 15:430. doi: 10.1186\/1745-6215-15-430","journal-title":"Trials"},{"key":"305_CR178","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1053\/j.ajkd.2013.12.016","volume":"63","author":"SN Salam","year":"2014","unstructured":"Salam SN, Eastell R, Khwaja A (2014) Fragility fractures and osteoporosis in CKD: pathophysiology and diagnostic methods. Am J Kidney Dis 63:1049\u20131059. doi: 10.1053\/j.ajkd.2013.12.016","journal-title":"Am J Kidney Dis"},{"key":"305_CR179","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/S0140-6736(10)62349-5","volume":"377","author":"TD Rachner","year":"2011","unstructured":"Rachner TD, Khosla S, Hofbauer LC (2011) Osteoporosis: now and the future. Lancet Lond Engl 377:1276\u20131287. doi: 10.1016\/S0140-6736(10)62349-5","journal-title":"Lancet Lond Engl"},{"key":"305_CR180","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s001980050224","volume":"10","author":"HK Genant","year":"1999","unstructured":"Genant HK, Cooper C, Poor G et al (1999) Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int 10:259\u2013264","journal-title":"Osteoporos Int"},{"key":"305_CR181","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/ki.2013.254","volume":"84","author":"RN Moorthi","year":"2013","unstructured":"Moorthi RN, Moe SM (2013) Recent advances in the noninvasive diagnosis of renal osteodystrophy. Kidney Int 84:886\u2013894. doi: 10.1038\/ki.2013.254","journal-title":"Kidney Int"},{"key":"305_CR182","first-page":"117","volume":"18","author":"G Coen","year":"2005","unstructured":"Coen G (2005) Adynamic bone disease: an update and overview. J Nephrol 18:117\u2013122","journal-title":"J Nephrol"},{"key":"305_CR183","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000168681","volume":"14","author":"AJ Hutchison","year":"1994","unstructured":"Hutchison AJ, Whitehouse RW, Freemont AJ et al (1994) Histological, radiological, and biochemical features of the adynamic bone lesion in continuous ambulatory peritoneal dialysis patients. Am J Nephrol 14:19\u201329","journal-title":"Am J Nephrol"},{"key":"305_CR184","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1093\/ndt\/12.10.2144","volume":"12","author":"MM Couttenye","year":"1997","unstructured":"Couttenye MM, D\u2019Haese PC, Deng JT et al (1997) High prevalence of adynamic bone disease diagnosed by biochemical markers in a wide sample of the European CAPD population. Nephrol Dial Transplant 12:2144\u20132150","journal-title":"Nephrol Dial Transplant"},{"key":"305_CR185","first-page":"83","volume":"11","author":"S Belbrik","year":"1990","unstructured":"Belbrik S, Marie A, Boudailliez B et al (1990) Prevalence of histological types of bone disease in a hemodialysis center limiting the oral intake of aluminum hydroxide. N\u00e9phrologie 11:83\u201390","journal-title":"N\u00e9phrologie"},{"key":"305_CR186","first-page":"437","volume":"13","author":"A Gerakis","year":"2000","unstructured":"Gerakis A, Hadjidakis D, Kokkinakis E et al (2000) Correlation of bone mineral density with the histological findings of renal osteodystrophy in patients on hemodialysis. J Nephrol 13:437\u2013443","journal-title":"J Nephrol"},{"key":"305_CR187","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.semnephrol.2014.09.004","volume":"34","author":"PU Torres","year":"2014","unstructured":"Torres PU, Bover J, Mazzaferro S et al (2014) When, how, and why a bone biopsy should be performed in patients with chronic kidney disease. Semin Nephrol 34:612\u2013625. doi: 10.1016\/j.semnephrol.2014.09.004","journal-title":"Semin Nephrol"},{"key":"305_CR188","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1002\/jbmr.309","volume":"26","author":"HH Malluche","year":"2011","unstructured":"Malluche HH, Mawad HW, Monier-Faugere M-C (2011) Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients. J Bone Miner Res 26:1368\u20131376. doi: 10.1002\/jbmr.309","journal-title":"J Bone Miner Res"},{"key":"305_CR189","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/sj.ki.5002769","volume":"73","author":"FC Barreto","year":"2008","unstructured":"Barreto FC, Barreto DV, Moys\u00e9s RMA et al (2008) K\/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients. Kidney Int 73:771\u2013777. doi: 10.1038\/sj.ki.5002769","journal-title":"Kidney Int"},{"key":"305_CR190","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1053\/j.ajkd.2013.02.366","volume":"62","author":"S Sardiwal","year":"2013","unstructured":"Sardiwal S, Magnusson P, Goldsmith DJA, Lamb EJ (2013) Bone alkaline phosphatase in CKD-mineral bone disorder. Am J Kidney Dis 62:810\u2013822. doi: 10.1053\/j.ajkd.2013.02.366","journal-title":"Am J Kidney Dis"},{"key":"305_CR191","doi-asserted-by":"publisher","first-page":"287","DOI":"10.5414\/CN108407","volume":"82","author":"F Lima","year":"2014","unstructured":"Lima F, El-Husseini A, Monier-Faugere M-C et al (2014) FGF-23 serum levels and bone histomorphometric results in adult patients with chronic kidney disease on dialysis. Clin Nephrol 82:287\u2013295. doi: 10.5414\/CN108407","journal-title":"Clin Nephrol"},{"key":"305_CR192","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/oxfordjournals.ndt.a027356","volume":"11","author":"P Ballanti","year":"1996","unstructured":"Ballanti P, Wedard BM, Bonucci E (1996) Frequency of adynamic bone disease and aluminum storage in Italian uraemic patients\u2014retrospective analysis of 1429 iliac crest biopsies. Nephrol Dial Transplant 11:663\u2013667","journal-title":"Nephrol Dial Transplant"},{"key":"305_CR193","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1053\/j.ajkd.2015.01.025","volume":"65","author":"P Palcu","year":"2015","unstructured":"Palcu P, Dion N, Ste-Marie L-G et al (2015) Teriparatide and bone turnover and formation in a hemodialysis patient with low-turnover bone disease: a case report. Am J Kidney Dis 65:933\u2013936. doi: 10.1053\/j.ajkd.2015.01.025","journal-title":"Am J Kidney Dis"},{"key":"305_CR194","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1053\/j.jrn.2009.10.006","volume":"20","author":"R Dukkipati","year":"2010","unstructured":"Dukkipati R, Kovesdy CP, Colman S et al (2010) Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patients. J Ren Nutr 20:243\u2013254. doi: 10.1053\/j.jrn.2009.10.006","journal-title":"J Ren Nutr"},{"key":"305_CR195","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1093\/ndt\/gfp170","volume":"24","author":"LF Morrone","year":"2009","unstructured":"Morrone LF, Mazzaferro S, Russo D et al (2009) Interaction between parathyroid hormone and the Charlson comorbidity index on survival of incident haemodialysis patients. Nephrol Dial Transplant 24:2859\u20132865. doi: 10.1093\/ndt\/gfp170","journal-title":"Nephrol Dial Transplant"},{"key":"305_CR196","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1093\/ndt\/gfv099","volume":"30","author":"JL Fern\u00e1ndez-Mart\u00edn","year":"2015","unstructured":"Fern\u00e1ndez-Mart\u00edn JL, Mart\u00ednez-Camblor P, Dionisi MP et al (2015) Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study. Nephrol Dial Transplant 30:1542\u20131551. doi: 10.1093\/ndt\/gfv099","journal-title":"Nephrol Dial Transplant"},{"key":"305_CR197","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1159\/000369039","volume":"40","author":"AT Mathew","year":"2014","unstructured":"Mathew AT, Hazzan A, Jhaveri KD et al (2014) Increasing hip fractures in patients receiving hemodialysis and peritoneal dialysis. Am J Nephrol 40:451\u2013457. doi: 10.1159\/000369039","journal-title":"Am J Nephrol"},{"key":"305_CR198","doi-asserted-by":"publisher","first-page":"837573","DOI":"10.1155\/2013\/837573","volume":"2013","author":"W-C Liu","year":"2013","unstructured":"Liu W-C, Yen J-F, Lang C-L et al (2013) Bisphophonates in CKD patients with low bone mineral density. ScientificWorldJournal 2013:837573. doi: 10.1155\/2013\/837573","journal-title":"ScientificWorldJournal"},{"key":"305_CR199","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1053\/j.ajkd.2015.03.012","volume":"66","author":"R Hiramatsu","year":"2015","unstructured":"Hiramatsu R, Ubara Y, Sawa N et al (2015) Denosumab for low bone mass in hemodialysis patients: a noncontrolled trial. Am J Kidney Dis 66:175\u2013177. doi: 10.1053\/j.ajkd.2015.03.012","journal-title":"Am J Kidney Dis"},{"key":"305_CR200","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1053\/j.ajkd.2010.02.340","volume":"55","author":"K Uhlig","year":"2010","unstructured":"Uhlig K, Berns JS, Kestenbaum B et al (2010) KDOQI US commentary on the 2009 KDIGO clinical practice guideline for the diagnosis, evaluation, and treatment of CKD-mineral and bone disorder (CKD-MBD). Am J Kidney Dis 55:773\u2013799. doi: 10.1053\/j.ajkd.2010.02.340","journal-title":"Am J Kidney Dis"},{"key":"305_CR201","first-page":"377","volume":"11","author":"P Bolasco","year":"1994","unstructured":"Bolasco P, Altieri P (1994) Pulses di calcitriolo endovena nel trattamento dell\u2019iperparatiroidismo secondario nei pazienti in emodialisi cronica: esperienza a lungo termine. G Ital Nefrol 11:377\u2013382","journal-title":"G Ital Nefrol"},{"key":"305_CR202","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1093\/ndt\/gfs108","volume":"27","author":"M Cozzolino","year":"2012","unstructured":"Cozzolino M, Brancaccio D, Cannella G et al (2012) VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH\u00a0\u2264150\u00a0pg\/ml: results of the Italian FARO Survey. Nephrol Dial Transplant 27:3588\u20133594. doi: 10.1093\/ndt\/gfs108","journal-title":"Nephrol Dial Transplant"},{"key":"305_CR203","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1024\/0300-9831\/a000192","volume":"84","author":"RB Jansen","year":"2014","unstructured":"Jansen RB, Svendsen OL (2014) The effect of oral loading doses of cholecalciferol on the serum concentration of 25-OH-vitamin-D. Int J Vitam Nutr Res 84:45\u201354. doi: 10.1024\/0300-9831\/a000192","journal-title":"Int J Vitam Nutr Res"},{"key":"305_CR204","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/ki.2011.69","volume":"80","author":"D Russo","year":"2011","unstructured":"Russo D, Corrao S, Battaglia Y et al (2011) Progression of coronary artery calcification and cardiac events in patients with chronic renal disease not receiving dialysis. Kidney Int 80:112\u2013118. doi: 10.1038\/ki.2011.69","journal-title":"Kidney Int"},{"key":"305_CR205","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s40620-014-0071-2","volume":"28","author":"D Russo","year":"2015","unstructured":"Russo D, Bellasi A, Pota A et al (2015) Effects of phosphorus-restricted diet and phosphate-binding therapy on outcomes in patients with chronic kidney disease. J Nephrol 28:73\u201380. doi: 10.1007\/s40620-014-0071-2","journal-title":"J Nephrol"},{"key":"305_CR206","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/ckj\/sfv073","volume":"8","author":"L Lullo Di","year":"2015","unstructured":"Di Lullo L, Gorini A, Bellasi A et al (2015) Fibroblast growth factor 23 and parathyroid hormone predict extent of aortic valve calcifications in patients with mild to moderate chronic kidney disease. Clin Kidney J 8:732\u2013736. doi: 10.1093\/ckj\/sfv073","journal-title":"Clin Kidney J"},{"key":"305_CR207","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000362862","volume":"38","author":"D Russo","year":"2014","unstructured":"Russo D, Morrone LF, Errichiello C et al (2014) Impact of BMI on cardiovascular events, renal function, and coronary artery calcification. Blood Purif 38:1\u20136. doi: 10.1159\/000362862","journal-title":"Blood Purif"},{"key":"305_CR208","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/sj.ki.5000045","volume":"69","author":"DL Andress","year":"2006","unstructured":"Andress DL (2006) Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation. Kidney Int 69:33\u201343. doi: 10.1038\/sj.ki.5000045","journal-title":"Kidney Int"},{"key":"305_CR209","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv111","author":"G Schlieper","year":"2015","unstructured":"Schlieper G, Schurgers L, Brandenburg V et al (2015) Vascular calcification in chronic kidney disease: an update. Nephrol Dial Transplant. doi: 10.1093\/ndt\/gfv111","journal-title":"Nephrol Dial Transplant"},{"key":"305_CR210","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1161\/CIRCULATIONAHA.107.706127","volume":"117","author":"TJ Wang","year":"2008","unstructured":"Wang TJ, Pencina MJ, Booth SL et al (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117:503\u2013511. doi: 10.1161\/CIRCULATIONAHA.107.706127","journal-title":"Circulation"},{"key":"305_CR211","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.2337\/diacare.27.12.2813","volume":"27","author":"R Scragg","year":"2004","unstructured":"Scragg R, Sowers M, Bell C, Health Third National, Survey Nutrition Examination (2004) Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 27:2813\u20132818","journal-title":"Diabetes Care"},{"key":"305_CR212","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.2337\/diacare.28.5.1228","volume":"28","author":"ES Ford","year":"2005","unstructured":"Ford ES, Ajani UA, McGuire LC, Liu S (2005) Concentrations of serum vitamin D and the metabolic syndrome among US adults. Diabetes Care 28:1228\u20131230","journal-title":"Diabetes Care"},{"key":"305_CR213","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1001\/archinte.167.11.1159","volume":"167","author":"D Martins","year":"2007","unstructured":"Martins D, Wolf M, Pan D et al (2007) Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 167:1159\u20131165. doi: 10.1001\/archinte.167.11.1159","journal-title":"Arch Intern Med"},{"key":"305_CR214","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1172\/JCI15219","volume":"110","author":"YC Li","year":"2002","unstructured":"Li YC, Kong J, Wei M et al (2002) 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110:229\u2013238. doi: 10.1172\/JCI15219","journal-title":"J Clin Invest"},{"key":"305_CR215","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv041","author":"G Schlieper","year":"2015","unstructured":"Schlieper G, Hess K, Floege J, Marx N (2015) The vulnerable patient with chronic kidney disease. Nephrol Dial Transplant. doi: 10.1093\/ndt\/gfv041","journal-title":"Nephrol Dial Transplant"},{"key":"305_CR216","doi-asserted-by":"publisher","first-page":"F1088","DOI":"10.1152\/ajprenal.00474.2004","volume":"289","author":"T Shimada","year":"2005","unstructured":"Shimada T, Yamazaki Y, Takahashi M et al (2005) Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism. Am J Physiol Renal Physiol 289:F1088\u2013F1095. doi: 10.1152\/ajprenal.00474.2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"305_CR217","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/ki.2010.432","volume":"79","author":"MS Razzaque","year":"2011","unstructured":"Razzaque MS (2011) The dualistic role of vitamin D in vascular calcifications. Kidney Int 79:708\u2013714. doi: 10.1038\/ki.2010.432","journal-title":"Kidney Int"},{"key":"305_CR218","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1096\/fj.08-123992","volume":"23","author":"T Nakatani","year":"2009","unstructured":"Nakatani T, Ohnishi M, Razzaque MS (2009) Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model. FASEB J 23:3702\u20133711. doi: 10.1096\/fj.08-123992","journal-title":"FASEB J"},{"key":"305_CR219","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1161\/01.CIR.0000160353.27927.70","volume":"111","author":"D Somjen","year":"2005","unstructured":"Somjen D, Weisman Y, Kohen F et al (2005) 25-Hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation 111:1666\u20131671. doi: 10.1161\/01.CIR.0000160353.27927.70","journal-title":"Circulation"},{"key":"305_CR220","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/BF02555253","volume":"41","author":"J Merke","year":"1987","unstructured":"Merke J, Hofmann W, Goldschmidt D, Ritz E (1987) Demonstration of 1,25(OH)2 vitamin D3 receptors and actions in vascular smooth muscle cells in vitro. Calcif Tissue Int 41:112\u2013114","journal-title":"Calcif Tissue Int"},{"key":"305_CR221","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1161\/01.CIR.96.6.1755","volume":"96","author":"KE Watson","year":"1997","unstructured":"Watson KE, Abrolat ML, Malone LL et al (1997) Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 96:1755\u20131760","journal-title":"Circulation"},{"key":"305_CR222","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1681\/ASN.2008111157","volume":"20","author":"IH Boer de","year":"2009","unstructured":"de Boer IH, Kestenbaum B, Shoben AB et al (2009) 25-Hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol JASN 20:1805\u20131812. doi: 10.1681\/ASN.2008111157","journal-title":"J Am Soc Nephrol JASN"},{"key":"305_CR223","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1161\/ATVBAHA.108.165886","volume":"28","author":"ML Melamed","year":"2008","unstructured":"Melamed ML, Muntner P, Michos ED et al (2008) Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol 28:1179\u20131185. doi: 10.1161\/ATVBAHA.108.165886","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"305_CR224","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/j.1365-2265.2006.02633.x","volume":"65","author":"G Targher","year":"2006","unstructured":"Targher G, Bertolini L, Padovani R et al (2006) Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol (Oxf) 65:593\u2013597. doi: 10.1111\/j.1365-2265.2006.02633.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"305_CR225","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s40620-014-0167-8","volume":"28","author":"Q-Y Zhang","year":"2015","unstructured":"Zhang Q-Y, Jiang C-M, Sun C et al (2015) Hypovitaminosis D is associated with endothelial dysfunction in patients with non-dialysis chronic kidney disease. J Nephrol 28:471\u2013476. doi: 10.1007\/s40620-014-0167-8","journal-title":"J Nephrol"},{"key":"305_CR226","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1681\/ASN.2006060573","volume":"18","author":"GM London","year":"2007","unstructured":"London GM, Gu\u00e9rin AP, Verbeke FH et al (2007) Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol JASN 18:613\u2013620. doi: 10.1681\/ASN.2006060573","journal-title":"J Am Soc Nephrol JASN"},{"key":"305_CR227","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00019501-199809080-00007","volume":"9","author":"Y Arad","year":"1998","unstructured":"Arad Y, Spadaro LA, Roth M et al (1998) Serum concentration of calcium, 1,25 vitamin D and parathyroid hormone are not correlated with coronary calcifications. An electron beam computed tomography study. Coron Artery Dis 9:513\u2013518","journal-title":"Coron Artery Dis"},{"key":"305_CR228","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.545","author":"JM Valdivielso","year":"2008","unstructured":"Valdivielso JM, Ayus JC (2008) Role of vitamin D receptor activators on cardiovascular risk. Kidney Int Suppl. doi: 10.1038\/ki.2008.545","journal-title":"Kidney Int Suppl"},{"key":"305_CR229","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0272-6386(97)90571-0","volume":"30","author":"F Takahashi","year":"1997","unstructured":"Takahashi F, Finch JL, Denda M et al (1997) A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content. Am J Kidney Dis 30:105\u2013112","journal-title":"Am J Kidney Dis"},{"key":"305_CR230","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.2215\/CJN.02140309","volume":"4","author":"K Kalantar-Zadeh","year":"2009","unstructured":"Kalantar-Zadeh K, Kovesdy CP (2009) Clinical outcomes with active versus nutritional vitamin D compounds in chronic kidney disease. Clin J Am Soc Nephrol CJASN 4:1529\u20131539. doi: 10.2215\/CJN.02140309","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"305_CR231","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1053\/ajkd.2001.28114","volume":"38","author":"F Llach","year":"2001","unstructured":"Llach F, Yudd M (2001) Paricalcitol in dialysis patients with calcitriol-resistant secondary hyperparathyroidism. Am J Kidney Dis 38:S45\u2013S50","journal-title":"Am J Kidney Dis"},{"key":"305_CR232","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1681\/ASN.V981427","volume":"9","author":"KJ Martin","year":"1998","unstructured":"Martin KJ, Gonz\u00e1lez EA, Gellens M et al (1998) 19-Nor-1-alpha-25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis. J Am Soc Nephrol JASN 9:1427\u20131432","journal-title":"J Am Soc Nephrol JASN"},{"key":"305_CR233","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1053\/ajkd.2001.28110","volume":"38","author":"SM Sprague","year":"2001","unstructured":"Sprague SM, Lerma E, McCormmick D et al (2001) Suppression of parathyroid hormone secretion in hemodialysis patients: comparison of paricalcitol with calcitriol. Am J Kidney Dis 38:S51\u2013S56","journal-title":"Am J Kidney Dis"},{"key":"305_CR234","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/ki.2010.387","volume":"79","author":"J Cunningham","year":"2011","unstructured":"Cunningham J, Zehnder D (2011) New vitamin D analogs and changing therapeutic paradigms. Kidney Int 79:702\u2013707. doi: 10.1038\/ki.2010.387","journal-title":"Kidney Int"},{"key":"305_CR235","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/01.CIR.98.13.1302","volume":"98","author":"S Jono","year":"1998","unstructured":"Jono S, Nishizawa Y, Shioi A, Morii H (1998) 1,25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. Circulation 98:1302\u20131306","journal-title":"Circulation"},{"key":"305_CR236","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/01.ATV.20.2.317","volume":"20","author":"PA Price","year":"2000","unstructured":"Price PA, Faus SA, Williamson MK (2000) Warfarin-induced artery calcification is accelerated by growth and vitamin D. Arterioscler Thromb Vasc Biol 20:317\u2013327","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"305_CR237","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1681\/ASN.2007080902","volume":"19","author":"S Mathew","year":"2008","unstructured":"Mathew S, Lund RJ, Chaudhary LR et al (2008) Vitamin D receptor activators can protect against vascular calcification. J Am Soc Nephrol JASN 19:1509\u20131519. doi: 10.1681\/ASN.2007080902","journal-title":"J Am Soc Nephrol JASN"},{"key":"305_CR238","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1124\/jpet.106.101261","volume":"318","author":"JR Wu-Wong","year":"2006","unstructured":"Wu-Wong JR, Noonan W, Ma J et al (2006) Role of phosphorus and vitamin D analogs in the pathogenesis of vascular calcification. J Pharmacol Exp Ther 318:90\u201398. doi: 10.1124\/jpet.106.101261","journal-title":"J Pharmacol Exp Ther"},{"key":"305_CR239","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1359\/jbmr.070305","volume":"22","author":"A Card\u00fas","year":"2007","unstructured":"Card\u00fas A, Panizo S, Parisi E et al (2007) Differential effects of vitamin D analogs on vascular calcification. J Bone Miner Res 22:860\u2013866. doi: 10.1359\/jbmr.070305","journal-title":"J Bone Miner Res"},{"key":"305_CR240","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/sj.ki.5002406","volume":"72","author":"M Mizobuchi","year":"2007","unstructured":"Mizobuchi M, Finch JL, Martin DR, Slatopolsky E (2007) Differential effects of vitamin D receptor activators on vascular calcification in uremic rats. Kidney Int 72:709\u2013715. doi: 10.1038\/sj.ki.5002406","journal-title":"Kidney Int"},{"key":"305_CR241","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/01.hjh.0000166849.72721.1c","volume":"23","author":"D Haffner","year":"2005","unstructured":"Haffner D, Hocher B, M\u00fcller D et al (2005) Systemic cardiovascular disease in uremic rats induced by 1,25(OH)2D3. J Hypertens 23:1067\u20131075","journal-title":"J Hypertens"},{"key":"305_CR242","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/ndt\/gfg513","volume":"19","author":"T Shoji","year":"2004","unstructured":"Shoji T, Shinohara K, Kimoto E et al (2004) Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population. Nephrol Dial Transplant 19:179\u2013184","journal-title":"Nephrol Dial Transplant"},{"key":"305_CR243","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000190244","volume":"77","author":"DJ Goldsmith","year":"1997","unstructured":"Goldsmith DJ, Covic A, Sambrook PA, Ackrill P (1997) Vascular calcification in long-term haemodialysis patients in a single unit: a retrospective analysis. Nephron 77:37\u201343","journal-title":"Nephron"},{"key":"305_CR244","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1093\/ndt\/gfl098","volume":"21","author":"S Briese","year":"2006","unstructured":"Briese S, Wiesner S, Will JC et al (2006) Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease-impact of calcium and vitamin D therapy. Nephrol Dial Transplant 21:1906\u20131914. doi: 10.1093\/ndt\/gfl098","journal-title":"Nephrol Dial Transplant"},{"key":"305_CR245","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1093\/ndt\/gfh125","volume":"19","author":"GM Chertow","year":"2004","unstructured":"Chertow GM, Raggi P, Chasan-Taber S et al (2004) Determinants of progressive vascular calcification in haemodialysis patients. Nephrol Dial Transplant 19:1489\u20131496. doi: 10.1093\/ndt\/gfh125","journal-title":"Nephrol Dial Transplant"},{"key":"305_CR246","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.2215\/CJN.00260109","volume":"4","author":"DV Barreto","year":"2009","unstructured":"Barreto DV, Barreto FC, Liabeuf S et al (2009) Vitamin D affects survival independently of vascular calcification in chronic kidney disease. Clin J Am Soc Nephrol CJASN 4:1128\u20131135. doi: 10.2215\/CJN.00260109","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"305_CR247","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","volume":"342","author":"WG Goodman","year":"2000","unstructured":"Goodman WG, Goldin J, Kuizon BD et al (2000) Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478\u20131483. doi: 10.1056\/NEJM200005183422003","journal-title":"N Engl J Med"},{"key":"305_CR248","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","volume":"62","author":"GM Chertow","year":"2002","unstructured":"Chertow GM, Burke SK, Raggi P, Treat to Goal Working Group (2002) Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62:245\u2013252. doi: 10.1046\/j.1523-1755.2002.00434.x","journal-title":"Kidney Int"},{"key":"305_CR249","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1681\/ASN.2007090993","volume":"19","author":"R Shroff","year":"2008","unstructured":"Shroff R, Egerton M, Bridel M et al (2008) A bimodal association of vitamin D levels and vascular disease in children on dialysis. J Am Soc Nephrol JASN 19:1239\u20131246. doi: 10.1681\/ASN.2007090993","journal-title":"J Am Soc Nephrol JASN"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-016-0305-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-016-0305-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-016-0305-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-016-0305-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:57:33Z","timestamp":1777564653000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/29\/3\/305\/8371416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,9]]},"references-count":249,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["305"],"URL":"https:\/\/doi.org\/10.1007\/s40620-016-0305-6","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726277945.793521856","asserted-by":"object"}]},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,9]]}}}